Christopher completed his Bachelor’s degree in Biomedical Sciences with a speciality in Pharmacology at Université de Montréal. As part of his bachelor’s training, and under the supervision of Dr. Daniel G. Bichet andDr. Jean-Yves Lapointe, he studied the role and trafficking of several membrane proteins such as Aquaporin-2 and SGLT2 in the pathophysiology of nephrogenic diabetes insipidus and type 2 diabetes respectively. He recently completed his Master’s degree in Pharmacology at Université de Montréal (Dr. Vincent Pichette’s laboratory) where he studied the underlying mechanisms of impaired glucose metabolism in chronic kidney disease and in related metabolic complications (i.e. secondary hyperparathyroidism).